疾病修饰治疗与复发性多发性硬化症患者的治疗结果的关联以及孤立的MRI活动

Gabriel Bsteh1, Marie L Aicher1, Janette F Walde1

  • 1From the Department of Neurology (G.B., N.K., K.R., P.A., B.K., F.L., P.S.R., G.Z., T.Z., T.B.), and Comprehensive Center for Clinical Neurosciences & Mental Health (G.B., N.K., K.R., P.A., B.K., F.L., P.S.R., G.Z., T.Z., T.B.), Medical University of Vienna, Austria; Department of Neurology (M.L.A., A.S., A.C., R.H., H. Hammer), Inselspital, Bern University Hospital and University of Bern, Switzerland; Department of Statistics (J.F.W.), Faculty of Economics and Statistics, University of Innsbruck; Department of Biomedical Imaging and Image Guided Therapy (L.H.), Clinical Department of Neuroradiology and Musculoskeletal Radiology, Medical University of Vienna; Department of Neurology 2 (G.T.), Med Campus III, Kepler University Hospital GmbH, Linz; Department of Neurology (C.G.), Medical University of St. Pölten; and Departments of Neuroradiology (P.P.) and Neurology (P.L., M.A., K.B., F.D.P., F.D., H. Hegen), Medical University of Innsbruck, Austria.

Neurology
|August 28, 2024
PubMed
概括

对于在初始治疗中稳定的复发性多发性硬化症 (RMS) 患者,根据MRI发现至少有两个新的T2病变,根据MRI发现的不断升级的疾病修饰疗法 (DMT) 显著降低了复发风险.